Corn Futures Higher Following USDA Reports -- Daily Grain Highlights

▤ Summary

Pacira BioSciences announced an agreement to sell its iovera° business to Zimmer Biomet for up to $140 million. The deal includes $70 million upfront and up to $70 million in milestone payments tied to future revenue performance. The two companies will also collaborate on advancing the spasticity program, with Pacira eligible for additional compensation if development and regulatory milestones are achieved. Pacira plans to use the proceeds to strengthen its balance sheet and pay down debt, and the transaction is expected to close in the third quarter of 2026.

▦ Linked Companies